Multi-program deal with revenue potential of $100 million per target SAN DIEGO, Aug. 15, 2026 /PRNewswire/ -- Aizen Therapeutics, an AI-native biotechnology company focused on building oral biologics, today announced a multi-program collaboration with a San Diego-based, public biotech to...
Hence then, the article about aizen enters into collaboration with san diego biopharma to advance oral biologics was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Aizen Enters into Collaboration with San Diego Biopharma to Advance Oral Biologics )
Also on site :
- Delve Back Into the World of Vampires and Chocolate Factories With Deluxe Editions Released This Week
- Michael B. Jordan paid $5.8 million for a Los Angeles house in 2019 and listed it for $6,988,000 in 2022; it returned to the market in September for $14 million
- Kenya confirms first Ebola case after patient dies